Volume 96, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Reported herein is the first case of –human immunodeficiency virus (HIV) coinfection in Ecuador. In Ecuador, HIV infections overlap endemic areas of leishmaniasis. Immunosuppression is a well-established risk factor for developing severe disease. This is a severe case of a 32-year-old man presenting with disseminated pleomorphic ulcers, papules, and cutaneous plaque-like lesions over his whole body. Numerous amastigotes were observed in both skin scrapings and biopsies. The sequence of the gene confirmed the presence of . The patient was treated but failed to respond to meglumine antimoniate and amphotericin B. Six months later, the patient died due to bacterial septic shock.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. van Griensven J, Carrillo E, López-Vélez R, Lynen L, Moreno J, , 2014. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect 20: 286299.[Crossref] [Google Scholar]
  2. Alvar J, Aparicio P, Aseffa A, Den Boer M, Cañavate C, Dedet JP, Gradoni L, Ter Horst R, López-Vélez R, Moreno J, , 2008. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev 21: 334359.[Crossref] [Google Scholar]
  3. Parmentier L, Cusini A, Müller N, Zangger H, Hartley M-A, Desponds C, Castiglioni P, Dubach P, Ronet C, Beverley SM, Fasel N, , 2016. Case report: severe cutaneous leishmaniasis in a human immunodeficiency virus patient coinfected with Leishmania braziliensis and its endosymbiotic virus. Am J Trop Med Hyg 94: 840843.[Crossref] [Google Scholar]
  4. Guerra JAO, Coelho LIRC, Pereira FR, Siqueira AM, Ribeiro RL, Almeida TML, Lacerda MVG, Barbosa MDGV, Talhari S, , 2011. American tegumentary leishmaniasis and HIV-AIDS association in a tertiary care center in the Brazilian Amazon. Am J Trop Med Hyg 85: 524527.[Crossref] [Google Scholar]
  5. Couppié P, Clyti E, Sobesky M, Bissuel F, Del Giudice P, Sainte-Marie D, Dedet JP, Carme B, Pradinaud R, , 2004. Comparative study of cutaneous leishmaniasis in human immunodeficiency virus (HIV)-infected patients and non-HIV-infected patients in French Guiana. Br J Dermatol 151: 11651171.[Crossref] [Google Scholar]
  6. Vélez Nieto L, , 2008. Leishmaniasis En La Región de Las Américas. Reunión de Coordinadores de Programa Nacional de Leishmaniasis. Medellín, Colombia: Ministerio de Salud. [Google Scholar]
  7. Calvopina M, Armijos RX, Hashiguchi Y, , 2004. Epidemiology of leishmaniasis in Ecuador: current status of knowledge: a review. Mem Inst Oswaldo Cruz 99: 663672.[Crossref] [Google Scholar]
  8. Calvopina M, Romero Alvarez D, Kato H, Hashiguchi Y, , 2014. Lesión cutánea esporotricoide en un paciente procedente de una región subtropical de Ecuador. Enferm Infecc Microbiol Clin 32: 465466.[Crossref] [Google Scholar]
  9. Calvopina M, Armijos RX, Marco JD, Uezato H, Kato H, Gomez EA, Korenaga M, Barroso PA, Mimori T, Cooper PJ, Nonaka S, Hashiguchi Y, , 2006. Leishmania isoenzyme polymorphisms in Ecuador: relationships with geographic distribution and clinical presentation. BMC Infect Dis 6: 139.[Crossref] [Google Scholar]
  10. Calvopina M, Loor R, Lara F, Zambrano P, Hashiguchi Y, , 2012. Prevalencia y formas clínicas de las leishmaniasis en el noroccidente de la provincia de Pichincha: Ecuador. Rev Fac Cienc Med 37: 3138. [Google Scholar]
  11. Kato H, Gomez EA, Martini-Robles L, Muzzio J, Velez L, Calvopina M, Romero-Alvarez D, Mimori T, Uezato H, Hashiguchi Y, , 2016. Geographic distribution of Leishmania species in Ecuador based on the cytochrome b gene sequence analysis. PLoS Negl Trop Dis 10: e0004844.[Crossref] [Google Scholar]
  12. Programa Nacional del Sida (PNS), 2010. Análisis de la Situación del VIH en el Ecuador. Documento de Trabajo. Ministerio de Salud Pública del Ecuador, 145. [Google Scholar]
  13. Programa Nacional de Prevención y Control del VIH/Sida-ITS, 2010. Informe Nacional sobre los Progresos Realizados en la Aplicación del UNGASS. Quito, Ecuador: Ministerio de Salud Pública, 1234. [Google Scholar]
  14. Lindoso JAL, Barbosa RN, Posada-Vergara MP, Duarte MIS, Oyafuso LK, Amato VS, Goto H, , 2009. Unusual manifestations of tegumentary leishmaniasis in AIDS patients from the New World. Br J Dermatol 160: 311318.[Crossref] [Google Scholar]
  15. Armijos RX, Weigel MM, Calvopina M, Mancheno M, Rodriguez R, , 2004. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis. Acta Trop 91: 153160.[Crossref] [Google Scholar]
  16. Armijos RX, Weigel MM, Izurieta R, Racines J, Zurita C, Herrera W, Vega M, , 1997. The epidemiology of cutaneous leishmaniasis in subtropical Ecuador. Trop Med Int Health 2: 140152.[Crossref] [Google Scholar]
  17. Torrico F, Parrado R, Castro R, Marquez CJ, Torrico MC, Solano M, Reithinger R, García AL, , 2009. Case report: co-infection of Leishmania (Viannia) braziliensis and HIV: report of a case of mucosal leishmaniasis in Cochabamba, Bolivia. Am J Trop Med Hyg 81: 555558.[Crossref] [Google Scholar]
  18. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents, 2015. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed January 4, 2017. [Google Scholar]

Data & Media loading...

  • Received : 27 May 2016
  • Accepted : 19 Dec 2016
  • Published online : 13 Feb 2017

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error